Business

October 17, 2013 10:36 AM

Chimerix shareholders selling 2.48 million shares

Chimerix shareholders plan to sell 2.48 million shares, the Durham drug developer said in a regulatory filing.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs